As of today (2024-04-24), Ebos Group's share price is A$31.65.
Ebos Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.20. Hence, Ebos Group's Price-to-Free-Cash-Flow Ratio for today is 26.33.
The historical rank and industry rank for Ebos Group's Price-to-Free-Cash-Flow or its related term are showing as below:
ASX:EBO'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.36 Med: 22.66 Max: 46.64
Current: 26.35
During the past 13 years, Ebos Group's highest Price-to-Free-Cash-Flow Ratio was 46.64. The lowest was 11.36. And the median was 22.66.
ASX:EBO's Price-to-Free-Cash-Flow is ranked worse than 65.57% of 61
companies
in the Medical Distribution industry
Industry Median: 20.94
vs ASX:EBO: 26.35
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Ebos Group was 11.90% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 8.10% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 17.90% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 10.10% per year.
During the past 13 years, Ebos Group's highest 3-Year average Free Cash Flow per Share Growth Rate was 64.70% per year. The lowest was -40.90% per year. And the median was 14.65% per year.
Ebos Group Price-to-Free-Cash-Flow Historical Data
The historical data trend for Ebos Group's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ebos Group's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group Price-to-Free-Cash-Flow Distribution
For the Medical Distribution industry and Healthcare sector, Ebos Group's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Ebos Group's Price-to-Free-Cash-Flow falls into.
Ebos Group Price-to-Free-Cash-Flow Calculation
Ebos Group's Price-to-Free-Cash-Flow ratio for today is calculated as
Ebos Group's Share Price of today is A$31.65.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.20.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Ebos Group (ASX:EBO) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Ebos Group Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Ebos Group's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:EBO has been successfully added to your 